U.S. Auto Components Stock News

In early February 2026, U.S. Physical Therapy announced that its subsidiary Metro Physical & Aquatic Therapy entered a 10-year alliance with NYU Langone Health, bringing 60 Long Island and New York metropolitan outpatient clinics into NYU Langone's clinical services network. This long-term partnership links a large regional clinic footprint with a major academic health system, potentially reshaping U.S. Physical Therapy's role in a key higher-reimbursement geography. Next, we'll examine how...

Verizon Communications Inc. ( NYSE:VZ ) shares have had a really impressive month, gaining 26% after a shaky period...

Innovative Aerosystems, Inc. reported past first-quarter fiscal 2026 results with revenue rising to US$21.81 million and net income to US$4.06 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. The company linked this step-up in profitability to growing commercial and defense demand, progress on new avionics platforms like UMS2 and Liberty Flight Deck, and infrastructure expansions that support its longer-term revenue and margin...

RenaissanceRe Holdings' board has increased its quarterly dividend to US$0.41 per share, up from US$0.40, and completed recent share repurchases totaling more than US$900.00 million, with the higher dividend payable on March 31, 2026 to shareholders of record on March 13, 2026. These steady dividend increases for over three decades, combined with sizable buybacks in late 2025 and early 2026, highlight management’s consistent emphasis on returning capital to shareholders alongside recent...

In February 2026, Atomera Incorporated reported fourth-quarter 2025 sales of US$50,000 with a net loss of US$4.43 million, and full-year 2025 sales of US$65,000 with a net loss of US$20.17 million, alongside updated Delaware law-aligned bylaws. Alongside these results, Atomera highlighted progress integrating its MST technology into advanced Gate-All-Around transistor structures and GaN-on-silicon applications, supported by a new major equipment OEM partnership and collaborations with...

Rockwell Automation (ROK) is back in focus after its latest quarter showed revenue of US$2,105 million and net income of US$305 million, alongside a modest uptick in full year earnings guidance. See our latest analysis for Rockwell Automation. The earnings beat, raised full year guidance and ongoing buybacks have come alongside a 1 year total shareholder return of 36.15% and a 5 year total shareholder return of 75.37%. The current share price of US$394.37 follows a recent 7.75% 90 day share...

Some Renasant Corporation ( NYSE:RNST ) shareholders may be a little concerned to see that insider Milton Cole recently...

Atara Biotherapeutics, Inc.'s ( NASDAQ:ATRA ) price-to-sales (or "P/S") ratio of 0.2x might make it look like a strong...

Anyone interested in Aehr Test Systems, Inc. ( NASDAQ:AEHR ) should probably be aware that the Founder & Independent...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...

Agnico Eagle Mines Limited ( NYSE:AEM ) has announced that it will be increasing its dividend from last year's...

Eversource Energy ( NYSE:ES ) will increase its dividend from last year's comparable payment on the 31st of March to...

The board of Vishay Intertechnology, Inc. ( NYSE:VSH ) has announced that it will pay a dividend on the 26th of March...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Those following along with Northpointe Bancshares, Inc. ( NYSE:NPB ) will no doubt be intrigued by the recent purchase...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...

We wouldn't blame Fifth Third Bancorp ( NASDAQ:FITB ) shareholders if they were a little worried about the fact that...

It's not a stretch to say that Fuel Tech, Inc.'s ( NASDAQ:FTEK ) price-to-sales (or "P/S") ratio of 1.6x right now...

Targa Resources (TRGP) is back in focus after reporting record adjusted EBITDA of US$1.27b in Q3 2025, issuing a higher full-year outlook, advancing major Permian growth projects, and outlining plans for a higher dividend. See our latest analysis for Targa Resources. The recent Q3 earnings beat, higher outlook and new Permian projects have coincided with a 20.8% 1 month share price return and a 32.0% 3 month share price return. The 3 year total shareholder return of more than 3x suggests...

Guidewire Software (GWRE) drew fresh attention after reporting record fiscal Q1 sales activity, securing new cloud contracts with The Hartford and Sompo, and raising full year guidance across all key performance metrics. See our latest analysis for Guidewire Software. Even with the recent contracts and raised guidance, Guidewire’s share price has been under pressure, with a 30 day share price return of 20.1% decline and a year to date share price return of 32.3% decline. However, the 3 year...

Hilltop Holdings Inc. recently presented at the KBW 2026 Winter Financial Services Conference in Boca Raton and filed its latest annual 10-K, outlining current performance and business priorities across its banking, broker-dealer, and mortgage operations. The combination of detailed disclosures on segment performance, opportunities in acquisitions and technology, and upbeat analyst coverage has sharpened investor focus on Hilltop’s business mix and long-term positioning. With its recent 10-K...

What Tyson’s beef losses and new bond issue mean for stock investors Tyson Foods (TSN) is facing sustained pressure in its beef business, with consecutive quarterly losses tied to higher cattle costs and a smaller US herd, even as the company taps bond markets for fresh funding. See our latest analysis for Tyson Foods. The recent bond issue, ongoing beef losses and a softer earnings quarter come against a backdrop where Tyson’s 90 day share price return of 19.16% and 1 year total shareholder...

Spyre Therapeutics (SYRE) is in focus after growing investor interest in its clinical-stage pipeline for inflammatory bowel disease, particularly its monoclonal antibody candidates SPY001 and SPY002, along with broad analyst support for the stock. See our latest analysis for Spyre Therapeutics. The recent clinical pipeline interest has come alongside strong momentum, with a 10.2% 1 month share price return, a 52% 3 month share price return and a 59.8% 1 year total shareholder return. The...

Cousins Properties reported past full-year 2025 results with revenue of US$993.82 million and net income of US$40.5 million, while also acquiring the fully leased 638,000-square-foot 300 South Tryon office property in Uptown Charlotte for US$317.5 million. The combination of higher sales and revenue with a premium, fully occupied Charlotte asset funded partly by non-core asset sales highlights Cousins’ focus on strengthening its Sun Belt office portfolio and income visibility. We’ll now...